Company · founded 1991
BioScience Laboratories (United States)
Bozeman, United States · biosciencelabs.com
- Citations, last 5 years
- 9
- Works, last 5 years
- 4
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 188
Grants received
2013–2020 · contract · N01
Simian Vaccine Evaluation Unit - Operations of a Nonhuman Primate Breeding Colony
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
SVEU - Operation of a NHP Breeding Colony
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2021 · contract · N01
SVEU - Final Transition and Continued Operation of the Nonhuman Primate Breeding Colony During Transition
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
NIAID Preclinical Development Support - Production of Research Cell Lines
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
NIAID Preclinical Development Support - Production of Research Cell Lines
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X8: Stability Testing of a Malaria Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X14: Malaria Vaccine Candidate Stability Studies
Jim Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X13: Product Characterization and Process Development
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X10: Cell Bank Work for Agilvax
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X9: Agilvax Phage Display for Multiple Vaccine Candidates
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X1: Manufacture and Characterization Services for Vaccines and Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X12: Development of a Gonorrhea Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X4: Generation of a Shigella Vaccine Master Cell Bank
William Coale · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X8: Stability Testing of a Malaria Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2025 · contract · N01
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X12: Development of a Gonorrhea Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X10: Manufacture and Characterization Services for Vaccines
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X8: Stability Testing of a Malaria Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X20:Master Cell Banks
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X8: Stability Testing of Malaria Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
